Composition
- Active ingredients
- STAVUDINE 37.5MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- STAVUDINE 100MG · Capsule, extended releaseNDA021453-004 · Discontinued
- STAVUDINE 50MG · Capsule, extended releaseNDA021453-002 · Discontinued
- STAVUDINE 75MG · Capsule, extended releaseNDA021453-003 · Discontinued
- STAVUDINE 37.5MG · Capsule, extended releaseThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021453.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Zerit XR
- Active substance
- stavudine
- Route
- Oral
- Dosage form
- Capsule, extended release
- Applicant
- Bristol Myers Squibb
- Status
- Discontinued
- FDA approval
- 31 Dec 2002
- Application
- NDA021453-001